Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM
暂无分享,去创建一个
L. Pleyer | R. Greil | S. Jilg | F. Huemer | K. Steiger | P. Jost | T. Melchardt | E. Klieser | A. Egle | Bettina Jansko | Sigrun Greil-Ressler | T. Magnes | A. Wahida | C. Rass